Excellent efficacy of Chong Kun Dang’s ‘Duvie’ published in international journal
Chong Kun Dang(CEO Young-Joo Kim) announced on the 12th that a study result which structurally revealed strong antidiabetic efficacy and little incidence of adverse drug reactions with a new diabetes therapy ‘Duvie(generic name: lobeglitazone)’ was in Scientific Reports, a U.K. scientific journal...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
